Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a… Read More
Vaccine startup Curevo takes on pharma giant GSK, raises $60M for trial of shingles shot Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the… Read More
Seattle’s HDT Bio to start U.S. clinical trials of its COVID-19 vaccine candidate An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company… Read More
Tech Moves: Heavily-funded real estate tech startup Compass hires former Distelli and Amazon exec Rahul Singh; and more Former “Geek of the Week” Rahul Singh is now VP of engineering at New York real estate broker Compass, where… Read More
